PEN
Penumbra Inc
Key Financials
Gross Profit
$942.4M
↑ 24.8%
Operating Income
$189.2M
↑ 1939.5%
Net Income
$177.7M
↑ 1168.1%
Revenue
$764.8M
N/A
EPS (Diluted)
$4.52
↑ 1155.6%
Total Assets
$1.8B
↑ 19.1%
Total Liabilities
$398.9M
↑ 4.4%
Shareholders' Equity
$1.4B
↑ 24.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/17/2026 | View on SEC |
| 4 | 8/19/2026 | View on SEC |
| SCHEDULE 13G | 8/13/2026 | View on SEC |
| 10-Q | 7/30/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| SD | 5/29/2026 | View on SEC |
| 4 | 5/21/2026 | View on SEC |
| 425 | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PEN |
| Company Name | Penumbra Inc |
| CIK | 1321732 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (510) 995-2486 |